Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
13.52
+0.29 (2.19%)
At close: Jun 26, 2026, 4:00 PM EDT
13.73
+0.21 (1.56%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Zevra Therapeutics Market Cap
Zevra Therapeutics has a market cap or net worth of $799.24 million as of June 26, 2026. Its market cap has increased by 55.83% in one year.
Market Cap
799.24M
Enterprise Value
599.77M
1-Year Change
55.83%
Ranking
Category
Stock Price
$13.52
Market Cap Chart
Since April 16, 2015, Zevra Therapeutics's market cap has increased from $137.80M to $799.24M, an increase of 480.00%. That is a compound annual growth rate of 16.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 799.20M | 58.45% |
| Dec 31, 2025 | 504.40M | 13.30% |
| Dec 31, 2024 | 445.20M | 87.69% |
| Dec 29, 2023 | 237.20M | 49.75% |
| Dec 30, 2022 | 158.40M | -48.50% |
| Dec 31, 2021 | 307.60M | 505.51% |
| Dec 31, 2020 | 50.80M | 303.17% |
| Dec 31, 2019 | 12.60M | -73.25% |
| Dec 31, 2018 | 47.10M | -20.71% |
| Dec 29, 2017 | 59.40M | 37.50% |
| Dec 30, 2016 | 43.20M | -84.95% |
| Dec 31, 2015 | 287.00M | 108.27% |
| Apr 16, 2015 | 137.80M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Odyssey Therapeutics | 866.11M |
| Phathom Pharmaceuticals | 850.70M |
| Geron | 850.02M |
| ARS Pharmaceuticals | 839.11M |
| Design Therapeutics | 832.55M |
| Aura Biosciences | 769.89M |
| Climb Bio | 751.83M |
| CytomX Therapeutics | 735.84M |